默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

已收盘 11-21 16:00:00 EST

99.86

+2.42

+2.48%

盘后99.86

+0.000.00%

19:55 EST

最高100.48	最低96.95	成交量1,567万
今开97.72	昨收97.44	日振幅3.62%
总市值2,526亿	流通市值2,522亿	总股本25.30亿
成交额15.52亿	换手率0.62%	流通股本25.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":99.86,"timestamp":1732222800000,"preClose":97.44,"halted":0,"volume":15670302,"hourTrading":{"tag":"盘后","latestPrice":99.86,"preClose":99.86,"latestTime":"19:55 EST","volume":1670004,"amount":166767235.23671,"timestamp":1732236907131},"delay":0,"floatShares":2525118727,"shares":2529635645,"eps":4.779697,"marketStatus":"已收盘","marketStatusCode":5,"change":2.42,"latestTime":"11-21 16:00:00 EST","open":97.72,"high":100.48,"low":96.95,"amount":1552165570.907028,"amplitude":0.036227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.779697,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":-745790400000,"adjPreClose":97.44,"adrRate":0,"dividendRate":0.030443,"preHourTrading":{"tag":"盘前","latestPrice":97.68,"preClose":97.44,"latestTime":"09:29 EST","volume":23227,"amount":2263807.4769599997,"timestamp":1732199391073},"postHourTrading":{"tag":"盘后","latestPrice":99.86,"preClose":99.86,"latestTime":"19:55 EST","volume":1670004,"amount":166767235.23671,"timestamp":1732236907131},"volumeRatio":1.214015,"impliedVol":0.2573,"impliedVolPercentile":0.7937},"requestUrl":"/m/hq/s/MRK/tweets","defaultTab":"tweets","newsList":[{"id":"2485344611","title":"默沙东涨2.63% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2485344611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485344611?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:33","pubTimestamp":1732214023,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时33分，默沙东股票出现波动，股价急速拉升2.63%。截至发稿，该股报100.00美元/股，成交量669.864万股，换手率0.26%，振幅3.15%。默沙东股票所在的制药行业中，整体跌幅为0.24%。此外，默沙东还销售与动物健康相关的药物。继强生公司启动新一轮的裁员调整之后，另一家知名的跨国制药企业默沙东也在中国市场宣布了裁员计划。第一季度，裁员人数接近3000人，第二季度全球医药器械企业报告的裁员次数超过45次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202334498e43fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202334498e43fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051811.HKD","LU1941712348.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0265550359.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","BK4534","LU0965509010.AUD","LU0861579265.USD","LU1093756168.USD","LU0122379950.USD","LU1585245621.USD","LU2361044865.SGD","LU0965509101.SGD","LU2461242641.AUD","SG9999014567.USD","LU0058720904.USD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU0320765489.SGD","SG9999001176.USD","SGXZ57979304.SGD","SG9999014575.USD","IE0002141913.USD","LU0985320562.USD","LU2324357040.USD","BK4533","MRK","BK4516","IE00B1BXHZ80.USD","BK4588","BK4559","LU1291159041.SGD","LU2023250504.SGD","SG9999014559.SGD","LU1057294990.SGD","LU2361044949.HKD","LU1974910355.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU1934455277.USD","SG9999013999.USD","LU1037948897.HKD","LU0265550946.USD","BK4007","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0238689110.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2485412862","title":"默沙东上涨1.24%，报98.651美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485412862","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485412862?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:44","pubTimestamp":1732207468,"startTime":"0","endTime":"0","summary":"11月22日，默沙东(MRK)盘中上涨1.24%，截至00:44，报98.651美元/股，成交3.71亿美元。财务数据显示，截至2024年09月30日，默沙东收入总额485.44亿美元，同比增长6.73%；归母净利润133.74亿美元，同比增长740.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/22004445553277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1116320901.HKD","LU1093756168.USD","LU0265550946.USD","BK4516","LU0965509010.AUD","LU2023250504.SGD","LU0265550359.USD","LU1061106388.HKD","LU0106261372.USD","LU0965509283.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","IE00BBT3K403.USD","LU1023059063.AUD","IE00BN8TJ469.HKD","LU0234572021.USD","LU1066051498.USD","LU0070302665.USD","SG9999001176.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948897.HKD","LU0211331839.USD","BK4007","LU2023250843.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","SG9999014567.USD","IE00BJT1NW94.SGD","BK4533","LU1917777945.USD","LU1116320737.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU0965509101.SGD","SG9999002232.USD","LU1934455863.HKD","MRK","LU0965508806.USD","LU2461242641.AUD","SG9999014542.SGD","LU2089984988.USD","SG9999015358.SGD","LU2112291526.USD","LU0861579265.USD","BK4559","LU2324357040.USD","LU1066053197.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2485957914","title":"默沙东(MRK.US)HIF-2α抑制剂在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2485957914","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485957914?lang=zh_cn&edition=full","pubTime":"2024-11-21 21:12","pubTimestamp":1732194720,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月21日，国家药监局网站显示，默沙东(MRK.US)的Belzutifan片(贝组替凡片)获批上市，适应症为von Hippel-Lindau(VHL)病相关肾细胞癌(RCC)、中枢神经系统(CNS)血管母细胞瘤或胰腺神经内分泌肿瘤(pNET)。VHL是一种罕见的遗传性疾病，每3.6万人中就有1人患病。VHL患者不仅有罹患良性血管肿瘤的风险，也有罹患某些癌症的风险，包括肾细胞癌。Belzutifan是一款小分子缺氧诱导因子2α(HIF-2α)抑制剂，可以减少与细胞增殖、血管生成和肿瘤生长相关的HIF-2α靶基因的转录和表达。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0203345920.USD","LU0320765489.SGD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0234572021.USD","LU1037948541.HKD","BK4559","LU0965508806.USD","LU0265550946.USD","LU0965509010.AUD","LU1093756168.USD","LU1066051811.HKD","SG9999015341.SGD","LU0289739699.SGD","LU1093756325.SGD","BK4550","LU0006306889.USD","LU1066051225.USD","LU2112291526.USD","BK4516","LU2106854487.HKD","LU1116320901.HKD","MRK","IE00BSNM7G36.USD","IE0002141913.USD","BK4534","LU1291159041.SGD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU1585245621.USD","LU2361044949.HKD","BK4585","LU1983299246.USD","LU0266013472.USD","LU0965509101.SGD","LU0208291251.USD","SG9999014567.USD","LU2361044865.SGD","LU1066053197.SGD","SGXZ57979304.SGD","LU1934455863.HKD","SG9999002224.SGD","LU1023059063.AUD","LU1037948897.HKD","LU1934455194.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0265550359.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2485431246","title":"港股异动 | 和誉-B(02256)再涨近4% 匹米替尼III期临床结果公布 默克有较大可能行使全球商业化选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485431246","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485431246?lang=zh_cn&edition=full","pubTime":"2024-11-21 14:43","pubTimestamp":1732171390,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B午后再涨近4%，截至发稿，涨3.91%，报4.52港元，成交额1098.92万港元。据悉，2023年12月，和誉将pimicotinib大中华区商业化权益及全球权益优先选择权以总额最高达6.055亿美元的首付款、行权款及里程碑付款以及双位数销售分成授予默克。中金认为，pimicotinib有竞争力的TGCT和cGvHD数据有望成为默克行使海外选择权的重要参考，若行权则或在2025年为和誉带来可观的里程碑付款，增厚公司业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU0265550946.USD","MRK","LU1974910355.USD","SG9999001440.SGD","LU0320765489.SGD","IE0002141913.USD","LU0985320562.USD","IE00B1BXHZ80.USD","LU1066051498.USD","LU2461242641.AUD","BK4516","LU0122379950.USD","LU1057294990.SGD","LU0861579265.USD","LU1989772923.USD","LU1941712348.USD","LU0203345920.USD","LU1037948897.HKD","BK4533","SG9999001176.USD","SG9999013999.USD","LU1066051225.USD","LU1430594728.SGD","LU2361045086.USD","LU0965509010.AUD","III","LU0211331839.USD","BK4534","SG9999002232.USD","LU1116320901.HKD","SGXZ57979304.SGD","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","BK4559","LU1291159041.SGD","SG9999015341.SGD","LU0006306889.USD","BK4585","BK4134","LU0070302665.USD","LU0965508806.USD","SG9999015358.SGD","LU2023250504.SGD","LU1585245621.USD","LU1989771016.USD","LU0208291251.USD","LU1941712264.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2485810821","title":"牵手默沙东、获中生制药入股！礼新医药成创新药黑马，管线BD交易总额已超280亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2485810821","media":"时代周报","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485810821?lang=zh_cn&edition=full","pubTime":"2024-11-21 07:33","pubTimestamp":1732145585,"startTime":"0","endTime":"0","summary":"本文来源：时代周报 作者：杜苏敏短短一周时间，两笔BD（商务拓展）交易，且交易总额超过200亿元，创新药企业礼新医药一时间成为业内关注的焦点。11月20日，中国生物制药（01177.HK，下称“中生制药”）公告宣布，其与礼新医药签署了股权投资及战略合作协议。据此，中生制药将以1.42亿元的投资，获得礼新医药4.91%的股权，...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OAVdmM_-63ZvduFJMxBjAcjEaLNfEpC2fA6L6n6mV-puEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OAVdmM_-63ZvduFJMxBjAcjEaLNfEpC2fA6L6n6mV-puEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241121A0146400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241121A0146400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["01477","SG9999015341.SGD","LU2361044865.SGD","LU1585245621.USD","LU0234572021.USD","SG9999001176.USD","SG9999014567.USD","LU2324357040.USD","SG9999001440.SGD","LU1941712348.USD","LU0965509010.AUD","LU0006306889.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU0985320562.USD","LU2089984988.USD","LU1037948897.HKD","MRK","09939","BK4588","LU1093756325.SGD","LU1057294990.SGD","LU0265550359.USD","LU2023250843.SGD","IE00BBT3K403.USD","LU0058720904.USD","SG9999002232.USD","BK4007","LU2361045086.USD","IE00BLSP4452.SGD","06978","LU1037948541.HKD","IE00BSNM7G36.USD","LU0203347892.USD","LU1061106388.HKD","LU1291159041.SGD","LU1989771016.USD","LU0106261372.USD","LU1093756168.USD","LU1934455863.HKD","LU1989772923.USD","LU0208291251.USD","BK4534","BK4559","LU1066051498.USD","LU2023250504.SGD","LU2106854487.HKD","SG9999014542.SGD","IE00BLSP4239.USD","LU2361044949.HKD"],"gpt_icon":0},{"id":"2484148304","title":"默沙东上涨1.31%，报97.8美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148304","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148304?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:54","pubTimestamp":1732114494,"startTime":"0","endTime":"0","summary":"11月20日，默沙东(MRK)盘中上涨1.31%，截至22:54，报97.8美元/股，成交7088.46万美元。财务数据显示，截至2024年09月30日，默沙东收入总额485.44亿美元，同比增长6.73%；归母净利润133.74亿美元，同比增长740.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/20225445506612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00B2B36J28.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU0203347892.USD","LU0070302665.USD","LU0208291251.USD","SGXZ57979304.SGD","SG9999013999.USD","IE0002141913.USD","LU0289739699.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","BK4533","IE00BN8TJ469.HKD","LU0006306889.USD","IE00BLSP4452.SGD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0861579265.USD","LU1917777945.USD","LU2468319806.SGD","IE00BLSP4239.USD","IE0009355771.USD","SG9999002232.USD","MRK","LU1291159041.SGD","LU0965509101.SGD","LU2112291526.USD","LU1066051498.USD","LU1037948541.HKD","LU1941712264.USD","BK4559","LU2089984988.USD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1941712348.USD","LU0965509283.SGD","SG9999014567.USD","LU0211331839.USD","BK4588","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1430594728.SGD","BK4007","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2023250843.SGD","LU0106261372.USD","SG9999015358.SGD"],"gpt_icon":0},{"id":"2484166890","title":"媒体-随着本土竞争加剧，J&J和默克在华裁员 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2484166890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484166890?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:28","pubTimestamp":1732091290,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    11月20日 - -- 来源链接：  -- 注：路透未核实此报道，不保证其准确性","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","IE00B1BXHZ80.USD","LU1894683348.USD","LU0640476718.USD","SG9999015341.SGD","JNJ","LU1917777945.USD","LU1261432733.SGD","LU0912757837.SGD","LU0320765646.SGD","LU1066051811.HKD","IE00BVYPNW00.USD","MRK","IE00B3PB1722.GBP","LU1057294990.SGD","LU1116320737.USD","IE000M9KFDE8.USD","LU2023250504.SGD","LU2361045086.USD","SG9999001440.SGD","LU0882574055.USD","LU1037948897.HKD","LU2112291526.USD","LU1934455194.USD","BK4592","LU1061106388.HKD","SG9999014567.USD","SG9999015358.SGD","LU0889566641.SGD","LU1037948541.HKD","BK4007","LU1244550494.USD","LU1989771016.USD","LU1430594728.SGD","LU1267930813.SGD","SG9999013999.USD","LU0058720904.USD","LU0006306889.USD","LU1732800096.USD","LU0203345920.USD","LU0795875169.SGD","LU2089984988.USD","BK4516","IE0002141913.USD","LU1023059063.AUD","LU2023250843.SGD","LU0795875086.SGD","LU0965508806.USD","BK4504","BK4533"],"gpt_icon":0},{"id":"2484155652","title":"港股异动 | 和誉-B(02256)现涨超4% 匹米替尼III期临床试验结果公布 默克若选择行权将增厚公司业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2484155652","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484155652?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:49","pubTimestamp":1732081752,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和誉-B(02256)盘中涨超8%，截至发稿，涨4.15%，报4.27港元，成交额633.5万港元。消息面上，和誉公布，其附属和誉医药自主研发的CSF-1R小分子抑制剂匹米替尼治疗腱鞘巨细胞瘤(TGCT)患者的MANEUVER关键3期研究，取得积极顶线结果以及匹米替尼治疗TGCT的最新1期研究结果。据悉，2023年12月，和誉医药与德国默克公司就Pimicotinib达成独家许可协议。中金认为，pimicotinib有竞争力的TGCT和cGvHD数据有望成为默克行使海外选择权的重要参考，若行权则或在2025年为和誉带来可观的里程碑付款，增厚公司业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","03347","LU0320765489.SGD","02256","BK1576","BK4134","LU1066051225.USD","LU0265550359.USD","IE00B1BXHZ80.USD","BK1583","IE00BLSP4452.SGD","LU1093756325.SGD","SG9999014559.SGD","BK1161","LU1057294990.SGD","LU2361044949.HKD","SG9999001176.SGD","SG9999014567.USD","LU1093756168.USD","LU1061106388.HKD","LU1989772840.SGD","LU2324357040.USD","LU1116320901.HKD","LU0234572021.USD","BK4516","LU0965509283.SGD","SGXZ57979304.SGD","LU1066051811.HKD","III","LU1941712348.USD","LU2089984988.USD","SG9999015358.SGD","BK1141","LU0265550946.USD","LU0266013472.USD","LU0965509101.SGD","LU2112291526.USD","LU1934455277.USD","LU1941712264.USD","MRK","IE0009355771.USD","SG9999001440.SGD","LU0006306889.USD","SG9999002232.USD","BK4550","IE00BLSP4239.USD","IE0002141913.USD","SG9999014542.SGD","BK4007","LU2488822045.USD"],"gpt_icon":0},{"id":"2484663151","title":"牵手默沙东、阿斯利康、中生制药，礼新医药两年卖出280亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2484663151","media":"新康界","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484663151?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:23","pubTimestamp":1732080217,"startTime":"0","endTime":"0","summary":"11月20日早上，中国生物制药公告宣布，其与创新药企业礼新医药签署了股权投资及战略合作协议。先后牵手阿斯利康、默沙东，近三年礼新医药管线BD的交易总额至少已达280亿元。目前与中国生物制药的具体交易尚未可知，而仅算上与默沙东最新达成的总额可达32.88亿美元的交易，礼新医药近两年两款产品就卖出了近39亿美元，折合人民币超280亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120144131abd1322f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120144131abd1322f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU2456880835.USD","01177","IE0009355771.USD","LU0320765489.SGD","LU1934455277.USD","LU0070302665.USD","IE00BLSP4239.USD","LU2361044865.SGD","LU0109394709.USD","AZN","LU0208291251.USD","BK4568","LU1989771016.USD","LU2417539215.USD","LU1983299246.USD","LU1061106388.HKD","BK4550","IE000M9KFDE8.USD","LU1066053197.SGD","LU1941712348.USD","LU0861579265.USD","LU0965509101.SGD","SG9999001440.SGD","LU1934455194.USD","MRK","SG9999014559.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0238689110.USD","LU1057294990.SGD","LU2468319806.SGD","LU0234572021.USD","SG9999013999.USD","SG9999015341.SGD","LU1037948897.HKD","LU1093756325.SGD","LU0320765992.SGD","IE0002141913.USD","SG9999014567.USD","BK4533","IE00BSNM7G36.USD","BK4588","LU2236285917.USD","LU2462157665.USD","LU1989772840.SGD","SG9999014575.USD","LU0266013472.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2484110134","title":"专利悬崖危机解除？默沙东(MRK.US)Keytruda皮下注射版本达到3期试验主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110134","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110134?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:50","pubTimestamp":1732074641,"startTime":"0","endTime":"0","summary":"默沙东表示，在一项关键的3期试验中，皮下注射版本的抗PD1药物达到了主要目标，其表现与FDA批准的静脉注射版本相当，是肺癌的一线选择。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20241120/20241120114504_76998.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241120/20241120114504_76998.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1066051811.HKD","LU1941712348.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0203345920.USD","LU0265550359.USD","SG9999001176.SGD","LU1116320737.USD","LU2112291526.USD","BK4534","SG9999015341.SGD","LU1934455863.HKD","SG9999002224.SGD","LU0965509010.AUD","LU1023059063.AUD","LU1989772840.SGD","LU0861579265.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999002232.USD","LU1585245621.USD","LU2461242641.AUD","LU0106261372.USD","LU0058720904.USD","IE00BJT1NW94.SGD","SG9999014567.USD","LU1983299246.USD","LU1989771016.USD","IE0002141913.USD","MRK","LU1934455194.USD","BK4516","BK4588","LU1989772923.USD","BK4559","LU1291159041.SGD","LU2023250504.SGD","LU1116320901.HKD","LU0289739699.SGD","SG9999014559.SGD","LU0203347892.USD","LU1057294990.SGD","LU1974910355.USD","LU1066051498.USD","SG9999014542.SGD","LU1934455277.USD","IE00B4R5TH58.HKD","LU0238689110.USD","LU1061106388.HKD","LU2023250843.SGD"],"gpt_icon":0},{"id":"2484139314","title":"默沙东中国市场挑战加剧：业绩缩水，裁员计划开启","url":"https://stock-news.laohu8.com/highlight/detail?id=2484139314","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484139314?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:07","pubTimestamp":1732072058,"startTime":"0","endTime":"0","summary":"继强生公司启动新一轮的裁员调整之后，另一家知名的跨国制药企业默沙东也在中国市场宣布了裁员计划。然而，截至发稿前，默沙东中国方面尚未给出任何回复。默沙东的西格列汀是中国首款上市的DPP-4抑制剂，占据DPP-4抑制剂市场的榜首。上述相关人士指出，默沙东近期的裁员是由于糖尿病业务部门受到集采政策的较大冲击。从默沙东目前的业绩表现来看，PD-1业务板块为其贡献显著。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120111557a2475e98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120111557a2475e98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2023250843.SGD","LU1934455277.USD","LU1989771016.USD","LU1066051225.USD","LU0122379950.USD","LU2468319806.SGD","LU1093756168.USD","LU2324357040.USD","LU0106261372.USD","LU1291159041.SGD","SG9999001440.SGD","LU1934455863.HKD","LU1061106388.HKD","IE0009355771.USD","LU2023250504.SGD","IE00BLSP4239.USD","LU0070302665.USD","LU1037948897.HKD","LU2361044865.SGD","SG9999013999.USD","LU0211331839.USD","BK4533","MRK","YINN","LU1989772840.SGD","LU0266013472.USD","BK4585","LU1989772923.USD","LU2361044949.HKD","LU1093756325.SGD","LU2361045086.USD","LU0203347892.USD","SG9999002224.SGD","LU1057294990.SGD","IE00B2B36J28.USD","LU1037948541.HKD","LU1941712264.USD","SG9999002232.USD","LU1585245621.USD","LU1983299246.USD","SG9999001176.USD","LU1941712348.USD","LU1934455194.USD","LU0203345920.USD","IE00BJT1NW94.SGD","BK4534","IE00B1BXHZ80.USD","LU0861579265.USD","IE000M9KFDE8.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2484947569","title":"BUZZ-默克公司在发现注射用 Keytruda 与已获批准的静脉注射型相同后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947569","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484947569?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:08","pubTimestamp":1732025289,"startTime":"0","endTime":"0","summary":"11月19日 -  ** 默克公司MRK.N股价盘前上涨近1%至97.39美元 ** MRK最畅销药物Keytruda的注射版 ，该公司表示，在后期研究中，该药物的效果并不逊色于已获批准的静脉注射版。** MRK表示，该研究主要针对一种肺癌患者 ** 注射剂将 Keytruda 与透明质酸酶 alfa 结合在一起，透明质酸酶 alfa 是一种能帮助人体更好地吸收和扩散注射药物的酶。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4T3MQ18L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0234572021.USD","LU2023250504.SGD","LU1430594728.SGD","LU2112291526.USD","SG9999002224.SGD","LU0266013472.USD","LU2468319806.SGD","BK4588","LU0203345920.USD","LU0265550946.USD","LU0965509101.SGD","LU1983299246.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU0006306889.USD","LU0289739699.SGD","LU0965508806.USD","LU1093756325.SGD","SG9999014542.SGD","LU0965509283.SGD","BK4585","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0985320562.USD","LU1066051811.HKD","LU1934455194.USD","IE00BSNM7G36.USD","MRK","SG9999014575.USD","LU0861579265.USD","LU1037948541.HKD","LU1023059063.AUD","LU1917777945.USD","IE00B1BXHZ80.USD","LU1941712264.USD","LU1934455863.HKD","SG9999001176.SGD","SG9999014567.USD","LU0070302665.USD","SG9999001176.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1116320737.USD","IE00B4R5TH58.HKD","LU1989772923.USD","SG9999002232.USD","LU1061106388.HKD","SG9999015358.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2484434219","title":"又一家跨国药企在华人员优化 这次是默沙东中国糖尿病业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2484434219","media":"第一财经","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484434219?lang=zh_cn&edition=full","pubTime":"2024-11-19 20:23","pubTimestamp":1732019027,"startTime":"0","endTime":"0","summary":"继强生之后，又一家跨国药企传出裁员消息。有市场消息称，默沙东中国糖尿病业务因药品集采在裁员中。第一财经记者向默沙东中国官方求证，截至发稿时尚未获得回复。不过，第一财经记者从默沙东内部人士证实了该消息的真实性，但裁员幅度暂不详。默沙东旗下有三款糖尿病药物，分别是西格列汀、西格列汀二甲双胍、艾托格列净，前两款药物是公司糖尿病业务的主要销售来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411193244442093.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411193244442093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0208291251.USD","LU1066051811.HKD","LU2361044949.HKD","BK4585","LU1066053197.SGD","LU0203345920.USD","LU1037948541.HKD","LU1066051498.USD","SG9999014575.USD","IE00B1BXHZ80.USD","SG9999001440.SGD","LU1057294990.SGD","BK4588","LU1116320901.HKD","IE0002141913.USD","LU0106261372.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU0265550359.USD","SG9999014542.SGD","BK4533","LU1093756168.USD","SG9999014567.USD","LU0985320562.USD","LU1066051225.USD","IE00BJJMRZ35.SGD","LU2023250843.SGD","LU0211331839.USD","LU0289739699.SGD","SG9999001176.USD","LU1917777945.USD","LU0965509010.AUD","LU1061106388.HKD","LU2106854487.HKD","BK4550","IE00B2B36J28.USD","LU0006306889.USD","LU1037948897.HKD","LU2361045086.USD","LU1989772923.USD","MRK","LU1116320737.USD","BK4516","LU2112291526.USD","SGXZ57979304.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2023250504.SGD","SG9999013999.USD"],"gpt_icon":0},{"id":"2484948140","title":"国产分子在海外成为王炸","url":"https://stock-news.laohu8.com/highlight/detail?id=2484948140","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484948140?lang=zh_cn&edition=full","pubTime":"2024-11-19 20:04","pubTimestamp":1732017840,"startTime":"0","endTime":"0","summary":"上方“瞪羚社”即刻关注并加入社群      聚焦高成长公司，100000+投资菁英共同关注      近日，BionTech在完成普米斯双抗的BD交易后选择了更进一步：彻底收购了普米斯这家中国的多抗....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OHblOLnko3fTBs5rlhJDn9lNxReWWys99rJ7NItP5ybeUAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OHblOLnko3fTBs5rlhJDn9lNxReWWys99rJ7NItP5ybeUAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241119A08Z1Q00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241119A08Z1Q00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0238689110.USD","BK4585","LU1023059063.AUD","BK4534","LU1934455277.USD","SG9999001176.SGD","LU0070302665.USD","IE00BJT1NW94.SGD","IE00BBT3K403.USD","LU0266013472.USD","LU1989771016.USD","LU0985320562.USD","LU1941712264.USD","IE00BN8TJ469.HKD","LU0265550946.USD","LU0203345920.USD","BK4007","BK4107","SG9999002224.SGD","LU1093756168.USD","LU0234572021.USD","LU0289739699.SGD","LU1066053197.SGD","LU1430594728.SGD","IE0002141913.USD","LU2361044865.SGD","BK4533","LU2361044949.HKD","IE00B1BXHZ80.USD","BK4516","SG9999014559.SGD","LU1037948541.HKD","LU1934455863.HKD","LU1066051811.HKD","IE00BLSP4239.USD","LU1989772923.USD","L","SG9999013999.USD","LU0265550359.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","TRAE","LU1917777945.USD","LU1983299246.USD","LU2324357040.USD","LU0122379950.USD","LU1061106388.HKD","LU0861579265.USD","MRK","BK4550"],"gpt_icon":0},{"id":"2484917915","title":"默克公司称Keytruda注射液在试验中与已获批的静脉注射版效果相当","url":"https://stock-news.laohu8.com/highlight/detail?id=2484917915","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484917915?lang=zh_cn&edition=full","pubTime":"2024-11-19 19:46","pubTimestamp":1732016797,"startTime":"0","endTime":"0","summary":"    路透11月19日 - 默克公司  周二表示，一项研究表明，其抗癌药物Keytruda的注射剂并不比目前获批的静脉注射剂型差，这可能使其更容易获得和使用。默克公司研究部门肿瘤学、全球临床开发负责人玛乔丽-格林说，默克公司计划尽快与全球监管机构讨论这一结果。默克公司说，尽管给药时间短，但注射型药物在患者体内的暴露量以及在下一次给药前的浓度方面也并不逊色。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0965509101.SGD","LU2361044949.HKD","BK4550","LU0234572021.USD","LU0320765489.SGD","LU1917777945.USD","BK4516","BK4007","IE00B2B36J28.USD","LU1989771016.USD","LU0861579265.USD","LU1934455277.USD","LU2089984988.USD","LU0266013472.USD","SG9999001176.USD","LU1066051225.USD","IE00B1BXHZ80.USD","LU1093756325.SGD","LU1430594728.SGD","IE00BBT3K403.USD","LU1941712348.USD","BK4534","LU0211331839.USD","IE00BLSP4452.SGD","SG9999015341.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","BK4588","LU2023250504.SGD","SG9999014567.USD","SG9999015358.SGD","LU2023250843.SGD","LU2361045086.USD","SG9999014559.SGD","BK4533","LU0106261372.USD","LU0203345920.USD","SG9999002232.USD","LU0289739699.SGD","LU0070302665.USD","LU2468319806.SGD","LU0965509010.AUD","LU0985320562.USD","LU1066053197.SGD","LU1061106388.HKD","LU1116320737.USD","LU1037948541.HKD","MRK","LU1057294990.SGD"],"gpt_icon":0},{"id":"2484750961","title":"一周内官宣4笔BD交易！双抗新药赛道火爆，跨国药企砸百亿在华“扫货”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484750961","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484750961?lang=zh_cn&edition=full","pubTime":"2024-11-19 14:17","pubTimestamp":1731997033,"startTime":"0","endTime":"0","summary":"本文来源：时代财经 作者：李傲华双抗赛道日渐升温。11月18日，橙帆医药宣布与Avenzo Therapeutics达成一项全球战略合作协议，橙帆医药将授予Avenzo在全球范围内（不包括大中华区）开发、生产和商业化Nectin4/TROP2双特异性抗体偶联药物（ADC），同时保留在大中华区的相关权益。根据约定，橙帆医药可以获得5000万美元的首付...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241119A052YN00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241119A052YN00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU1057294990.SGD","LU0985320562.USD","SG9999013999.USD","LU0417516571.SGD","LU2461242641.AUD","BK4588","PML","LU1066053197.SGD","09939","LU0289739699.SGD","LU0106261372.USD","GSK","LU1934455863.HKD","BK4080","GSK.UK","LU1061106388.HKD","LU0203347892.USD","LU1116320901.HKD","MRK","LU0053671581.USD","BK4007","SG9999014542.SGD","09926","LU0266013472.USD","SGXZ57979304.SGD","LU1116320737.USD","SG9999015341.SGD","BK4211","LU2112291526.USD","LU2023250504.SGD","IE0002141913.USD","BMS","L","LU0965509010.AUD","IE00BJJMRZ35.SGD","ADC","SG9999001176.SGD","IE00BLSP4239.USD","BK4231","LU1023059063.AUD","BK4534","HR","IE00B1BXHZ80.USD","BK4107","ITT","02162","SG9999001176.USD","LU1934455194.USD","SG9999014559.SGD","PFS"],"gpt_icon":0},{"id":"2484626006","title":"默沙东：质疑Summit，成为Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626006","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484626006?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:10","pubTimestamp":1731928222,"startTime":"0","endTime":"0","summary":"LM-299刚刚进入1期临床，默沙东支付的首付款要高于Summit，可能一定程度上反应了：默沙东也有点着急了。正所谓，质疑Summit，成为Summit。结果公布之后，康方生物合作伙伴Summit股价连续多日大涨，市值一度高达245亿美元。9月份以来，Summit股价暴涨，引发了全球市场对于PD-1/VEGF双抗的关注，甚至可以说是热潮：全球药企，都开始围猎PD-1/VEGF双抗。BioNtech也证实BNT327的 3期试验计划重点针对此类患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118195550abcc68c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118195550abcc68c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1116320901.HKD","LU1291159041.SGD","LU0265550946.USD","IE00BLSP4452.SGD","BK4585","IE00B1BXHZ80.USD","LU1941712348.USD","SG9999015341.SGD","BK4007","LU0234572021.USD","MRK","SG9999014559.SGD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","LU1941712264.USD","LU2023250843.SGD","LU0861579265.USD","LU1116320737.USD","LU0965509010.AUD","SG9999013999.USD","LU1066053197.SGD","LU0211331839.USD","LU2089984988.USD","LU1989772840.SGD","LU1066051811.HKD","IE00BSNM7G36.USD","LU1066051225.USD","SG9999014542.SGD","LU1430594728.SGD","LU0208291251.USD","LU1093756168.USD","LU1934455863.HKD","LU1989772923.USD","LU1066051498.USD","BK4588","LU2361044865.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","SG9999001176.USD","SG9999002232.USD","LU0238689110.USD","LU2324357040.USD","LU1037948541.HKD","BK4533","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU2361045086.USD","BK4534"],"gpt_icon":0},{"id":"2484838426","title":"“新冠富豪”再加码，默沙东态度大转变，下一个大药机会来临","url":"https://stock-news.laohu8.com/highlight/detail?id=2484838426","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484838426?lang=zh_cn&edition=full","pubTime":"2024-11-17 17:02","pubTimestamp":1731834139,"startTime":"0","endTime":"0","summary":"2020年，成立12年的BioNTech凭借mRNA新冠疫苗一战成名，有“新冠富豪”之称。在本次交易完成后，BioNTech将获得普米斯候选药物管线及其双特异性抗体药物开发平台的全部权利。至此，HARMONi-2研究成为全球首个对比K药取得显著阳性结果的随机对照III期临床研究，在肿瘤免疫治疗领域引起了巨大反响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117170732a23f99ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117170732a23f99ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015341.SGD","LU1934455194.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0965509101.SGD","LU1585245621.USD","LU1430594728.SGD","LU0234572021.USD","LU2112291526.USD","SG9999014559.SGD","LU2324357040.USD","IE0009355771.USD","IE00BN8TJ469.HKD","SG9999014575.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU0006306889.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU1116320901.HKD","LU2089984988.USD","MRK","LU1093756325.SGD","SG9999015358.SGD","BK4516","LU0265550359.USD","IE00BBT3K403.USD","LU0058720904.USD","LU0965509283.SGD","SG9999002232.USD","BK4533","LU0265550946.USD","SG9999013999.USD","IE00BLSP4452.SGD","LU1037948541.HKD","LU0203347892.USD","LU1066053197.SGD","LU1989771016.USD","LU1291159041.SGD","LU1989772923.USD","BK4585","BK4550","LU1934455863.HKD","LU1983299246.USD","LU0208291251.USD","BK4559","LU2106854487.HKD","SG9999014542.SGD","LU0238689110.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2483565108","title":"近33亿美元！默沙东“牵手”礼新医药，PD-(L)1/VEGF领域交易频发","url":"https://stock-news.laohu8.com/highlight/detail?id=2483565108","media":"21世纪经济报道","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483565108?lang=zh_cn&edition=full","pubTime":"2024-11-16 12:32","pubTimestamp":1731731534,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明上海报道连日来，PD-（L）1/VEGF双特异性抗体领域迎来多起重磅交易。14日晚间，默沙东宣布已协议获得礼新医药新型在研PD-1/VEGF双特异性抗体LM-299的全球开发、生产和商业化独家许可。根据协议条款，礼新医药将获得5.88亿美元的首付款及最高27亿美元的里程碑付款。该交易预计将于2024年第四季度完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411163241601423.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411163241601423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1066051225.USD","IE0009355771.USD","LU0965508806.USD","SG9999013999.USD","LU2461242641.AUD","LU0058720904.USD","LU0234572021.USD","LU1169590202.USD","LU0208291251.USD","LU2106854487.HKD","LU0203347892.USD","LU1941712348.USD","09939","IE00B2B36J28.USD","LU0985320562.USD","IE00BN8TJ469.HKD","LU1983299246.USD","BK4007","LU1037948541.HKD","MRK","SG9999015358.SGD","LU0106261372.USD","SG9999015341.SGD","IE00BBT3K403.USD","SG9999014575.USD","LU2361045086.USD","LU1941712264.USD","LU1061106388.HKD","BK4559","BK4023","IE0002141913.USD","LU0965509101.SGD","LU2324357040.USD","PD","LU1917777945.USD","L","LU1116320737.USD","LU2023250843.SGD","BK1515","LU1093756168.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0203345920.USD","LU1169589451.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU0211331839.USD","LU0965509010.AUD","LU2089984988.USD"],"gpt_icon":0},{"id":"2483738558","title":"多种模式并驾齐驱 创新药出海捷报频传","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738558","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738558?lang=zh_cn&edition=full","pubTime":"2024-11-16 08:29","pubTimestamp":1731716986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1989772840.SGD","LU1066053197.SGD","LU2023250504.SGD","LU0265550946.USD","BK0196","LU0266013472.USD","SG9999002232.USD","LU0070302665.USD","LU0203345920.USD","BK4550","BK0060","LU0289739699.SGD","LU2361044865.SGD","BK1574","159992","LU1169589451.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","161726","PD","SG9999002224.SGD","LU1983299246.USD","SG9999001440.SGD","02162","LU1917777945.USD","LU2089984988.USD","LU1169590202.USD","IE00BN8TJ469.HKD","BK0188","LU1291159041.SGD","06978","BK1161","399441","LU1066051225.USD","LU1093756325.SGD","SG9999014575.USD","LU0208291251.USD","LU2106854487.HKD","SG9999014559.SGD","LU1064130708.USD","BK4534","LU1061106388.HKD","09939","159938","BK1583","LU2112291526.USD","MRK","600276","LU0985320562.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.164},{"period":"6month","weight":-0.2475},{"period":"1year","weight":-0.0467},{"period":"ytd","weight":-0.1062}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018595},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.02766},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}